Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib absorption, metabolism, excretion, and absolute bioavailability study in adults with advanced cancer
NL-OMON41940Active, not recruiting
- Sponsor
- TESARO, Inc.
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of niraparib in Nonhematologic neoplasms (3 arms), sponsored by TESARO, Inc. Primary endpoints: Absolute bioavailability of niraparib and Plasma niraparib pharmacokinetics in Part 1. Started Feb 2015; status: active, not recruiting.
02
Drugs
niraparib
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on NL-OMON41940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41940.